AMPD2 Regulates GTP Synthesis and Is Mutated in a Potentially Treatable Neurodegenerative Brainstem Disorder
| dc.authorid | Vaux, Keith/0000-0001-8738-5940|Zaki, Maha/0000-0001-7840-0002|Cantagrel, Vincent/0000-0002-5180-4848|Spencer, Emily/0000-0003-2650-4357|Lipton, Stuart/0000-0002-3490-1259; | |
| dc.contributor.author | Akizu, Naiara | |
| dc.contributor.author | Cantagrel, Vincent | |
| dc.contributor.author | Schroth, Jana | |
| dc.contributor.author | Cai, Na | |
| dc.contributor.author | Vaux, Keith | |
| dc.contributor.author | McCloskey, Douglas | |
| dc.contributor.author | Naviaux, Robert K. | |
| dc.date.accessioned | 2025-10-24T18:08:59Z | |
| dc.date.available | 2025-10-24T18:08:59Z | |
| dc.date.issued | 2013 | |
| dc.department | Malatya Turgut Özal Üniversitesi | |
| dc.description.abstract | Purine biosynthesis and metabolism, conserved in all living organisms, is essential for cellular energy homeostasis and nucleic acid synthesis. The de novo synthesis of purine precursors is under tight negative feedback regulation mediated by adenosine and guanine nucleotides. We describe a distinct early-onset neuro degenerative condition resulting from mutations in the adenosine monophosphate deaminase 2 gene (AMPD2). Patients have characteristic brain imaging features of pontocerebellar hypoplasia (PCH) due to loss of brainstem and cerebellar parenchyma. We found that AMPD2 plays an evolutionary conserved role in the maintenance of cellular guanine nucleotide pools by regulating the feedback inhibition of adenosine derivatives on de novo purine synthesis. AMPD2 deficiency results in defective GTP-dependent initiation of protein translation, which can be rescued by administration of purine precursors. These data suggest AMPD2-related PCH as a potentially treatable early-onset neurodegenerative disease. | |
| dc.description.sponsorship | California Institute for Regenerative Medicine; UCSD Christini Fund; Jane Botsford Johnson Foundation; NIH [P01HD070494, R01NS048453, P30NS047101]; Broad Institute grant [U54HG003067]; Simons Foundation Autism Research Initiative | |
| dc.description.sponsorship | We thank the families for their participation. We also thank B. Daignan-Fornier and B. Pinson for the tet-AMD1 plasmid and helpful advice, A. Hopper and T. Yoshihisa for the sen2-41 yeast strain, E. Masliah and S. Michael for human brain specimens, and S.J. Elledge for pINDUCER20 plasmid. We thank T. Friedman, W. Nyhan, B. Barshop, R. Evans, J. Cheng, and D. Wolf for helpful discussions. N.A. was supported by the California Institute for Regenerative Medicine. R.K.N. was supported by grants from the UCSD Christini Fund and the Jane Botsford Johnson Foundation. This work was supported by the NIH (P01HD070494, R01NS048453, and P30NS047101 for imaging support), Broad Institute grant U54HG003067 (to Eric Lander), the Center for Inherited Disease Research for genotyping, and the Simons Foundation Autism Research Initiative. | |
| dc.identifier.doi | 10.1016/j.cell.2013.07.005 | |
| dc.identifier.endpage | 517 | |
| dc.identifier.issn | 0092-8674 | |
| dc.identifier.issn | 1097-4172 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pmid | 23911318 | |
| dc.identifier.scopus | 2-s2.0-84881193117 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 505 | |
| dc.identifier.uri | https://doi.org/10.1016/j.cell.2013.07.005 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12899/3394 | |
| dc.identifier.volume | 154 | |
| dc.identifier.wos | WOS:000322629900006 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Cell Press | |
| dc.relation.ispartof | Cell | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_20251023 | |
| dc.subject | Protein-Synthesis; Pontocerebellar Hypoplasia; Nucleotide Depletion; Yeast; Deficiency; Deaminase; Toxicity; Purine; Gene; Phosphoribosyltransferase | |
| dc.title | AMPD2 Regulates GTP Synthesis and Is Mutated in a Potentially Treatable Neurodegenerative Brainstem Disorder | |
| dc.title.alternative | XAMPD2 regulates GTP synthesis and is mutated in a potentially treatable neurodegenerative brainstem disorder | |
| dc.type | Article |












